MENU
ORKA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Oruka Therapeutics (ORKA) Earnings Date & Reports
Oruka Therapeutics Inc a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications... Show more
A.I. Advisor
published Earnings
ORKA is expected to report earnings to rise 29.91% to -58 cents per share on November 18
Q3'26
Est.
$-0.58
Q4'25
Beat
by $0.27
Q3'25
Beat
by $0.01
Q2'25
Beat
by $0.20
Q1'25
Beat
by $0.04
The last earnings report on March 12 showed earnings per share of -44 cents, beating the estimate of -72 cents. With 362.37K shares outstanding, the current market capitalization sits at 6.59B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information